Olga A. Elisseeva

Induction of <i>WT1</i> (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

Akihiro Tsuboi, Tetsuya Taguchi, Tadashi Osaki et al. · Proceedings of the National Academy of Sciences · 2004 · 526 citations · Full text

Medicine, Immunology, Oncology +17

Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene ( WT1  ) product

Yoshio Oka, Olga A. Elisseeva, Akihiro Tsuboi et al. · Immunogenetics · 2000 · 246 citations

Life Sciences, Genetics, Immunology +16

Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme

Shuichi Izumoto, Akihiro Tsuboi, Tsuyoshi Suzuki et al. · Journal of neurosurgery · 2008 · 213 citations

Medicine, Immunology, Oncology +17

Cancer Immunotherapy Targeting Wilms’ Tumor Gene WT1 Product

Keiko Udaka, Akihiro Tsuboi, Olga A. Elisseeva et al. · The Journal of Immunology · 2000 · 210 citations · Full text

Life Sciences, Immunology, Oncology +17

Wilms tumor gene peptide-based immunotherapy for patients with overt Leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

Akihiro Tsuboi, Masaki Murakami, Manabu Hirai et al. · International Journal of Hematology · 2003 · 123 citations

Medicine, Immunology, Oncology +16